French biotech stock soars 25% after new data on experimental medicine
--------------------------------------------------------------------
Source: CNBC
Published: 2026-06-30 17:13 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Financial Markets, Law & Courts, Drugs, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease, clawing back heavy losses from earlier in the month when the same trial had investors questioning the future of the drug.
--------------------------------------------------------------------